The Michael J. Fox Foundation
This article is actively undergoing a major edit for a little while. To help avoid edit conflicts, please do not edit this page while this message is displayed. This page was last edited at 16:09, 20 January 2024 (UTC) (7 months ago) – this estimate is cached, . Please remove this template if this page hasn't been edited for a significant time. If you are the editor who added this template, please be sure to remove it or replace it with {{Under construction}} between editing sessions. |
Abbreviation | MJFF |
---|---|
Gegründet | October 31, 2000[1] |
Gründer | Michael J. Fox |
13-4141945[2] | |
Legal status | 501(c)(3) Non-profit |
Purpose | Funding research for better treatments and a cure for Parkinson's disease[2] |
Hauptsitz | New York City[2] |
Fields | Parkinson's disease clinical research |
Skip Irving[3] | |
Deborah W. Brooks[4] | |
Affiliations | MJFF Canada[2] |
Revenue (2015) | $98,886,808[5] |
Expenses (2015) | $96,607,583[5] |
Employees (2014) | 109[2] |
Volunteers (2014) | 17[2] |
Website | www |
The Michael J. Fox Foundation for Parkinson's Research is a US non-profit organization founded in 2000 by Canadian-American actor Michael J. Fox to find a cure for Parkinson's disease.
The organization funds grants directly to scientists it assesses as having the best chance of finding a cure.[4] It maintains closer control over and supervision of projects than is typical from other medical-research foundations.[4][6]
As of 2023, it had raised $2 billion for Parkinson's research projects.[7][4] According to Town and Country, in 2022 the organization funded more research than the US government.[4]
In 2023, a ten-year study funded by the organization, the Parkinson's Progression Markers Initiative, released results in Lancet Neurology showing Parkinson’s can be detected by the presence of a biomarker protein, abnormal alpha-synuclein.[4][8][9] It can be detected before the onset of symptoms.[10]
The organization hosts the Fox Trial Finder, a website for presenting clinical trials in Parkinson's disease clinical research.[11]
References
- ^ "The Michael J. Fox Foundation for Parkinson's Research Archived 2016-09-20 at the Wayback Machine". Division of Corporations. Delaware Department of State. Accessed on May 18, 2016.
- ^ a b c d e f "Form 990: Return of Organization Exempt from Income Tax". The Michael J. Fox Foundation for Parkinson's Research. Guidestar. December 31, 2014.
- ^ "Skip Irving | Parkinson's Disease". www.michaeljfox.org. Archived from the original on 2022-12-26. Retrieved 2022-12-26.
- ^ a b c d e f Goldman, Andrew (2023-11-02). "Michael J. Fox Didn't Get Mad, He Got Motivated". Town & Country Magazine. Retrieved 2024-01-20.
- ^ a b "The Michael J. Fox Foundation" (PDF). Foundation Center. Archived (PDF) from the original on 16 November 2017. Retrieved 16 November 2017.
- ^ Piller, Charles (2016-08-30). "As Parkinson's patients wait, Fox Foundation and scientist feud over drug trial". Stat. Retrieved 2024-01-20.
- ^ Burleson, Nate; Breen, Kerry (November 9, 2023). "Michael J. Fox talks funding breakthrough research for Parkinson's disease". CBS News. Archived from the original on November 24, 2023. Retrieved January 20, 2024.
- ^ Hodgson, J. L. (2023-04-17). "Michael J. Fox's foundation finds groundbreaking discovery about Parkinson's". Diario AS. Retrieved 2024-01-20.
- ^ Schnell, Mychael (2021-12-02). "Michael J. Fox Foundation studying early signs of Parkinson's disease". The Hill. Retrieved 2024-01-20.
- ^ Michaud, Mark. "What You Need to Know about the New Parkinson's Biomarker". University of Rochester Medical Center. Retrieved 2024-01-20.
- ^ Weiner, Michael W.; Nosheny, Rachel; Camacho, Monica; Truran-Sacrey, Diana; Mackin, R. Scott; Flenniken, Derek; Ulbricht, Aaron; Insel, Philip; Finley, Shannon; Fockler, Juliet; Veitch, Dallas (August 2018). "The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies". Alzheimer's & Dementia. 14 (8): 1063–1076. doi:10.1016/j.jalz.2018.02.021. ISSN 1552-5260. PMC 6126911. PMID 29754989.